We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Thiol-disulfide homeostasis in breast cancer patients.
- Authors
Eryilmaz, Mehmet; Kozanhan, Betül; Solak, Ibrahim; Çetinkaya, Çigdem; Neselioglu, Salim; Erel, Özcan; Eryilmaz, Mehmet Ali; Çetinkaya, Çigdem Damla
- Abstract
<bold>Objective: </bold>The aim of our study is to assess thiol-disulfide homeostasis (TDH), which is a biomarker of systemic oxidative stress, in breast cancer patients.<bold>Materials and Methods: </bold>Thirty-seven breast cancer patients and 31 age-matched healthy volunteers were enrolled in this study. Serum native thiol, disulfide, and total thiol levels and disulfide/native thiol, disulfide/total thiol, and native thiol/total thiol ratios were analyzed using a novel colorimetric method.<bold>Results: </bold>Serum native thiol level was statistically significantly lower in breast cancer patients (350.39 ± 7.15) than in healthy controls (380.60 ± 7.35) (P = 0.008). Serum disulfide level was statistically significantly higher in breast cancer patients (24.96 ± 0.85) than in healthy controls (19.25 ± 1.34) (P = 0.002).<bold>Conclusion: </bold>To our knowledge, this study is the first study in the literature that investigated TDH in breast cancer patients. We have concluded that an alteration in TDH due to oxidative stress is likely to have a role in the pathogenesis of breast cancer.
- Subjects
BREAST cancer; CANCER patients; HOMEOSTASIS; OXIDATIVE stress; CARCINOGENESIS
- Publication
Journal of Cancer Research & Therapeutics, 2019, Vol 15, Issue 5, p1062
- ISSN
0973-1482
- Publication type
journal article
- DOI
10.4103/jcrt.JCRT_553_17